Analyst Price Targets — VS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 22, 2024 6:41 am | Scott Buck | H.C. Wainwright | $3.00 | $2.78 | StreetInsider | Versus Systems Inc. (VS) PT Raised to $3 at H.C. Wainwright |
| May 23, 2024 6:40 am | Scott Buck | H.C. Wainwright | $1.50 | $1.43 | StreetInsider | Versus Systems Inc. (VS) PT Lowered to $1.50 at H.C. Wainwright |
| April 29, 2022 9:18 am | Scott Buck | H.C. Wainwright | $37.50 | $15.60 | TheFly | Versus Systems price target lowered to $2.50 from $3.50 at H.C. Wainwright |
Latest News for VS
VS-7375 Demonstrates Clinical Activity with a Favorable Safety and Tolerability Profile in TARGET-D 101 Phase 1/2 Clinical Trial in Patients with Advanced KRAS G12D-Mutated Solid Tumors
BOSTON--(BUSINESS WIRE)---- $VSTM #CRC--VS-7375 (investigational KRAS G12D ON/OFF inhibitor) demonstrates clinical activity with a favorable safety profile in TARGET-D 101 clinical trial.
Zacks Initiates Coverage of Versus With Neutral Recommendation
Discover why Zacks rates Versus as "Neutral", being the first on Wall Street to initiate coverage on the stock. Explore VS' improving cash flow and tighter cost controls amid customer concentration and profitability challenges.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for VS.
U.S. House Trading
No House trades found for VS.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.